Despite remarkable progress in the treatment of patients with psoriatic arthritis (PsA), the management of this chronic disease still poses major challenges [1]. In the following interview, Prof. Pascal Richette, MD, from Paris, explains how new therapies can help achieve ambitious goals in terms of efficacy, tolerability and patient satisfaction.
Partner
Autoren
- Dr. sc. nat. Jennifer Keim
Related Topics
You May Also Like
- Severe asthma
Check diagnosis and initiate phenotype-based therapy
- Chronic wounds
State-of-the-art wound management: pioneering innovations
- Allergic rhinitis
International consensus paper summarizes important facts
- Obesity
Possibilities of nutritional therapy
- Headache treatment
The therapy of migraine
- Uveal melanoma
Development of a CAR T-cell therapy for uveal melanoma
- Electrolyte disturbance
Hyponatremia in the outpatient setting
- Study report: Risk factors for hand eczema